- $15.54bn
- $16.18bn
- $4.03bn
- 88
- 52
- 81
- 87
Annual balance sheet for Hologic, fiscal year end - September 28th, USD millions except per share, conversion factor applied.
2020 September 26th | 2021 September 25th | 2022 September 24th | 2023 September 30th | 2024 September 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 701 | 1,170 | 2,340 | 2,723 | 2,334 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,029 | 943 | 618 | 626 | 600 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,222 | 3,169 | 3,862 | 4,185 | 3,823 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 572 | 648 | 551 | 580 | 630 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,196 | 8,920 | 9,071 | 9,139 | 9,156 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,239 | 1,327 | 938 | 1,207 | 1,037 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4,491 | 4,701 | 4,195 | 4,122 | 4,026 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,705 | 4,219 | 4,876 | 5,017 | 5,130 |
| Total Liabilities & Shareholders' Equity | 7,196 | 8,920 | 9,071 | 9,139 | 9,156 |
| Total Common Shares Outstanding |